Secondary tabs
Contact details
Mui Van Zandt
Main
Karel Kostev
Alternate
Publications
Data source publications
- Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic. AMA Psychiatry. 2023 Mar 1
- Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID ‐19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiology and Drug Safety (2022)
- Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. BMJ 2022
- Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS. Clin Epidemiol. 2022
- DARWIN EU® – Prevalence of rare blood cancers in Europe
Studies
List of studies that have been conducted using the data source
- Prescribing of zolpidem in the primary care setting in France, Germany and the UK during 2012. (Prescribing of zolpidem in IMS Germany/France/UK)
- A Nested Case-control Post-authorization Safety Study of Etoricoxib and Other Non-steroidal Anti-inflammatory Therapies in a Cohort of Patients with Ankylosing Spondylitis (AS) in the UK, France and Germany (MK-0663-163)
- Drug utilisation study (DUS) on flupirtine-containing products Retrospective drug utilisation study using patient-level databases to characterise prescribing practices of flupirtine-containing drugs during routine clinical use and assess the main reasons for prescription by representative groups of prescribers
- Indications for systemic fluoroquinolone prescribing in Europe: a descriptive population based study
- Tramadol prescribing: a drug utilisation study using electronic data from France, Germany and the UK
- A Joint Drug Utilisation Study (DUS) of valproate and related substances, in Europe, using databases
- Use of ondansetron in pregnant female patients in the IMS Disease Analyzer databases in France and Germany (Ondansetron use pregnancy)
- Utilisation of dulaglutide in European countries: A cross-sectional, multi-country and multi-source drug utilisation study using electronic health record databases (H9X-MC-B010)
- Post-authorisation Safety Study to Evaluate the Long-term Safety of Dexamfetamine (Amfexa) (PASS for dexamfetamine)
- Study of exposure and use patterns of alternatives to ranitidine-containing medicines in patients treated with ranitidine (Ranitidine)
- Trends in prescriptions of valproate and valpromide for bipolar disorder in IMS France and IMS Germany between 2010 and June 2016 and in UK THIN between 1999 and 2015
- Prevalence of hypereosinophilic syndrome (HES) in the paediatric population in EU (Hypereosinophilic syndrome in children)
- DARWIN EU® Characterization of patients with chronic hepatitis B and C
- Glucocorticoid-induced osteoporosis (GIOP): prescription patterns of glucocorticoids in paediatric patients
- Prevalence of narcolepsy in two European countries - France and Germany
- Incidence rates of morphoea, systemic sclerosis and scleroderma
- Incidence rates of Cutaneous T-Cell Lymphomas (CTCL) among patients with atopic dermatitis (AD)
- Background incidence rates of Interstitial Lung Disease
- DARWIN EU® DUS of Antibiotics in the ‘Watch’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
- Population incidence rates of pemphigoid in six European countries
- Immune thrombocytopenia following vaccination with DTaP-IPV or TdaP-IPV in children
- Prevalence of palmoplantar psoriasis and pustular psoriasis in children
- Drug utilisation study of macrolide-containing medicinal products during pregnancy
- Treatment patterns in patients with pulmonary arterial hypertension
- Prevalence of primary and secondary arterial hypertension in children and treatment with angiotensin II receptor blockers
- Prevalence of multiple myeloma
- Prevalence of immunocompromised patients with a diagnosis of cytomegalovirus infection
- Prevalence of Acute Liver Injury
- DARWIN EU® Multiple myeloma: patient characterisation, treatments and survival in the period 2012-2022
- DARWIN EU® Use of take-home naloxone for opioid overdose treatment
- DARWIN EU® Drug utilization study of prescription opioids
- DARWIN EU® - Co-prescribing of endothelin receptor antagonists (ERAs) and phosphodiesterate-5 inhibitors (PDE-5is) in pulmonary arterial hypertension (PAH)
- DARWIN EU® Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus
- Incidence of phimosis and paraphimosis in patients treated with SGLT2 inhibitors
- DARWIN EU® EHDS Use Case: Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV-2 in the context of the OMICRON variant
- DARWIN EU® Drug utilisation study of medicines with prokinetic properties in children and adults diagnosed with gastroparesis
- DARWIN EU® Natural history of dermatomyositis (DM) and polymyositis (PM) in adults and paediatric populations
- DARWIN EU® Rates of occurrence of treatment-related intercurrent events in patients with major depressive disorder
- DARWIN EU® Age specific incidence rates of RSV related disease in Europe
- DARWIN EU® Monitoring prescription of medicines for public health emergencies at risk of shortages
- DARWIN EU® Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer
- DARWIN EU® – Frailty and polypharmacy among adults with selected cancers at the time of diagnosis
- Association between use of direct oral anticoagulants (DOACs) and increased risk of interstitial lung disease
- DARWIN EU® - Drug utilisation study on medicinal use of Pelargonii radix
- DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications
- DARWIN EU® - Drug Utilisation Study on GLP-1 Receptor Agonists
- DARWIN EU® - Drug utilisation study on medicinal use of cannabis flos
- DARWIN EU® - CGRP antagonists - Treatment patterns and users characteristics
- Association between exposure to esomeprazole/omeprazole and risk of sexual dysfunction in men
- DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe
- DARWIN EU® - Azathioprine - user characteristics
- DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® - Antipsychotic prescribing in the general population in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® - DUS Characterising STOPP criteria medication use in people with recurrent falls
- DARWIN EU® - Incidence of myoclonus in heart failure: a descriptive analysis in patients treated with sacubitril/valsartan and other treatments
- DARWIN EU® - Antipsychotic prescribing in people with dementia in Europe: a descriptive analysis of trends and patient characteristics
- DARWIN EU® -Drug utilisation of salbutamol products for inhalation and therapeutic alternative inhalation products
- DARWIN EU® - Characterising the use of JAK inhibitors in Europe: a Drug Utilisation Study
- DARWIN EU® – Incidence rates of venous thromboembolic events in patients with selected cancers
- DARWIN EU® - Impact of risk minimisation measures related to the risk of meningioma in women using nomegestrol and chlormadinone
- DARWIN EU® – Monitoring prescription of medicines for public health emergencies at risk of shortages
- Meningioma medroxyprogesterone feasibility assessment in the IDA Germany and IMRD UK databases